All News

January 16, 2024

Data haul improves immunotherapy response prediction

Vanderbilt biostatisticians have developed an immunotherapy response model that outperforms existing predictive models.

By Paul Govern
January 16, 2024

‘Molecular Muse’ exhibit features Artist-in-Residence program’s science-inspired art

The “Molecular Muse” art exhibit on display in Light Hall is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program, which brings together scientists and artists to create and promote art as a visual science communication tool.

By Leigh MacMillan
January 11, 2024

New playroom supported by Dunkin’ allows pediatric patients a place where they feel comfortable to be themselves, have fun and heal

Infants and toddlers at Monroe Carell Jr. Children’s Hospital at Vanderbilt have a newly renovated space in which to play thanks to a $150,000 grant from Dunkin’ Joy in Childhood Foundation.

By Christina Echegaray
January 11, 2024

VUMC’s James Nichols to lead lab standards institute

James Nichols, PhD, medical director of Clinical Chemistry and Point-of-Care Testing at Vanderbilt University Medical Center, has begun a two-year term as president of the Clinical and Laboratory Standards Institute.

By Bill Snyder
January 10, 2024

Pediatric cystic fibrosis diagnosis and treatment center honored by CF Foundation

By Rachel Vitolo
January 8, 2024

Ronald Alvarez elected president of American Gynecological and Obstetrical Society

According to Alvarez, chair of the Department of Obstetrics and Gynecology at Vanderbilt University Medical Center, the status of women’s health in the U.S., particularly maternal health, is “appalling” for a nation with the resources we have.

By Danny Bonvissuto
January 5, 2024

The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK and Novo Nordisk

Bristol Myers Squibb, GSK and Novo Nordisk are the newest members of the Alliance for Genomic Discovery.
January 4, 2024

VUMC in the news, Jan. 9, 2024

January 4, 2024

Study finds significant increased risk of future health issues for youth who suffer nonfatal firearm injuries

A Vanderbilt study found that youth who suffer nonfatal firearm injuries have a significantly increased risk of hospitalizations, emergency department visits, outpatient visits and costs in the 12 months following injury compared to youth without a firearm injury.
By Jessica Pasley
January 4, 2024

Potential AML therapy induces leukemic stem cell death

Vanderbilt researchers are studying a potential therapy for acute myeloid leukemia that targets the residual leukemic stem cells in bone marrow after treatment that are responsible for relapses and drug resistance.
By Tom Wilemon
January 4, 2024

C.J. Stimson named Executive Vice President for Population Health

C.J. Stimson, MD, JD, assistant professor of Urology and Senior Vice President of Value Transformation in the Vanderbilt University Medical Center Office of Population Health, has been named Executive Vice President for Population Health.
By John Howser
January 4, 2024

David Posch assumes new role of Senior Vice President for Business Consulting

David Posch, MA, Executive Vice President for Vanderbilt University Medical Center’s (VUMC) Office of Population Health and Executive Director for Vanderbilt Health Affiliated Network (VHAN), has transitioned into the new role of Senior Vice President for Business Consulting
By John Howser
January 2, 2024

Team uses COVID-19 to test automated acute disease profiling

An automated solution for creating phenotyping algorithms, PheNorm, worked well to identify symptomatic COVID-19 cases in electronic health records, suggesting that automation could speed high-throughput phenotyping of acute disease.
By Paul Govern
1 … 94 95 96 97 98 … 149